Gamma aminobutyric acid (GABA) receptor agonists for acute stroke

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 2, 2013, Pages

  Liu, Jia ^a   Wang, Lu Ning ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CLOMETHIAZOLE; DIAZEPAM; PLACEBO; NEUROPROTECTIVE AGENT;

BRAIN FUNCTION; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; META ANALYSIS; MORTALITY RATE; PATIENT CARE; PRIORITY JOURNAL; RANKIN SCALE; REVIEW; RHINITIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CHLORMETHIAZOLE; DIAZEPAM; GABA AGONISTS; HUMANS; NEUROPROTECTIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 84875498712     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009622.pub2     Document Type: Review

References (47)

1. Wahlgren NG, Bornhov S, Sharma A, Cederin B, Rosolacci T, Ashwood T, et al.The Clomethiazole Acute Stroke Study (CLASS): Efficacy results in 545 patients classified as Total Anterior Circulation Syndrome (TACS). Journal of Stroke and Cerebrovascular Diseases 1999;8:231-9.
2. Wahlgren NG, Diez-Tejador E, Teitelbaum J, Arboix A, Leys D, Ashwood T, et al.Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients. Stroke 2000;31:82-5.
3. Wahlgren NG, Matias Guiu J, Lainez JM, Veloso F, Ranasinha K, Grossman E, et al.The Clomethiazole Acute Stroke Study (CLASS): safety results in 1, 356 patients with acute hemispheric stroke. Journal of Stroke and Cerebrovascular Diseases 2000;9:158-65.
4. Wahlgren NG, Ranasinha KW, Rosolacci T, Franke CL, van Erven PMM, Ashwood T, et al.Clomethiazole acute stroke study (CLASS). Results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Stroke 1999;30:21-8.
5. Lyden PD, Shuaib A, Ng K, Atkinson R, Ashwood T, Nordlund A, et al.The Clomethiazole Acute Stroke Study in Hemorrhagic Stroke (CLASS-H): final results. Journal of Stroke and Cerebrovascular Diseases 2000;9:268-75.
6. Lyden P, Shuaib A, Levin K, Atkinson RP, Rajput A, Wechsler L, et al.Clomethiazole acute stroke study in ischemic stroke (CLASS-I). Stroke 2002;33:122-9.
7. Lyden P, Jacoby M, Schim J, Albers G, Mazzeo P, Ashwood T, et al.The clomethiazole acute stroke study in tissue-type plasminogen activator-treated stroke (CLASS-T). Neurology 2001;57:1199-205.
8. Lodder J, van Raak L, Hilton A, Hardy E, Kessels A. Diazepam to improve acute stroke outcome: results of the early GABA-ergic activation study in stroke trial. A randomized double-blind placebo controlled trial. Cerebrovascular Diseases 2006;21:120-7.
9. Cucchiara B, Kasner SE, Wolk DA, Lyden PD, Knappertz VA, Ashwood T, et al.Lack of hemispheric dominance for consciousness in acute ischaemic stroke. Journal of Neurology, Neurosurgery and Psychiatry 2003;74:889-92.
10. Cucchiara BL, Kasner SE, Wolk DA, Lyden PD, Knappertz VA, Ashwood T, et al.Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Critical Care Medicine 2004;32:241-5.
11. Lodder J, Luijckx GJ, van Raak L, Kessels F. Diazepam treatment to increase the cerebral GABAergic activity in acute stroke: a feasibility study in 104 patients. Cerebrovascular Diseases 2000;10:437-40.
12. Lyden PD, Ashwood T, Claesson L, Odergren T, Friday GH, Martin-Munley S. The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: design of a phase III trial in the United States and Canada. Journal of Stroke and Cerebrovascular Diseases 1998;7:435-41.
13. Lyden P, Claesson L, Havstad S, Ashwood T, Lu M. Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes. Archives of Neurology 2004;61:1677-80.
14. Millis SR, Straube D, Iramaneerat C, Smith EV Jr, Lyden P. Measurement properties of the National Institutes of Health Stroke Scale for people with right- and left-hemisphere lesions: further analysis of the clomethiazole for acute stroke study-ischemic (class-I) trial. Archives of Physical Medicine and Rehabilitation 2007;88:302-8.
15. van Raak L, Hilton A, Kessels F, Lodder J. Implementing the EGASIS trial, an international multicenter acute intervention trial in stroke. Controlled Clinical Trials 2002;23:74-9.
16. Wester P, Strand T, Wahlgren NG, Ashwood T, Osswald G. An open study of clomethiazole in patients with acute cerebral infarction. Cerebrovascular Diseases 1998;8:188-90.
17. American Heart Association. 2002 Heart and Stroke Facts Statistical Update. Dallas: American Heart Association, 2001.
18. Alicke B, Schwartz-Bloom RD. Rapid down-regulation of GABAA receptors in the gerbil hippocampus following transient cerebral ischemia. Journal of Neurochemistry 1995;65:2808-11.
19. Bath PM, Iddenden R, Bath FJ, Orgogozo JM, Tirilazad International Steering Committee. Tirilazad for acute ischemic stroke. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD002087]
20. Bath PMW, Bath-Hextall FJ. Pentoxifylline, propentofylline and pentifylline for acute ischemic stroke. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD000162.pub2]
21. Candelise L, Ciccone A. Gangliosides for acute ischemic stroke. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000094]
22. Chi OZ, Hunter C, Liu X, Chi Y, Weiss HR. Effects of GABA(A) receptor blockade on regional cerebral blood flow and blood-brain barrier disruption in focal cerebral ischemia. Journal of Neurological Sciences 2011;301:66-70.
23. Cruz-Flores S. Ischemic stroke in emergency medicine. http://emedicine.medscape.com/article/1916852-overview (accessed 9 June 2011).
24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315:629-34.
25. Gandolfo C, Sandercock P, Conti M. Lubeluzole for acute ischemic stroke. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD001924]
26. Gasior M, Witkin JM, Goldberg SR, Munzar P. Chlormethiazole potentiates the discriminative stimulus effects of methamphetamine in rats. European Journal of Pharmacology 2004;494:183-9.
27. Hanna JP, Frank JI, Furlan AJ, Sila SA, Secic S. Prediction of worsening consciousness from edema after hemispheric infarction. Journal of Stroke and Cerebrovascular Diseases 1996;6:25-9.
28. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
29. Horn J, Limburg M. Calcium antagonists for acute ischemic stroke. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD001928]
30. Klassman L. Therapeutic hypothermia in acute stroke. Journal of Neuroscience Nursing 2011;43:94-103.
31. Marshall JW, Green AR, Ridley RM. Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures. Brain Research 2003;972:119-26.
32. Muir KW, Lees KR. Excitatory amino acid antagonists for acute stroke. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD001244]
33. Nelson RM, Green AR, Lambert DG, Hainsworth AH. On the regulation of ischemia-induced glutamate efflux from rat cortex by GABA: in vitro studies with GABA, clomethiazole and pentobarbitone. British Journal of Pharmacology 2000;130:1124-30.
34. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
35. Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age and Ageing 2009;38:27-32.
36. Simon RP, Greenberg DA, Aminoff MJ. Stroke. Clinical Neurology. 7th Edition. New York: McGraw-Hill, 2009:292-327.
37. Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30:1538-41.
38. Sydserff SG, Borelli AR, Green AR, Cross AJ. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat: studies on dose, plasma concentration and therapeutic time window. British Journal of Pharmacology 2002;135:103-12.
39. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Arnao V, Renda C, Pinto A, et al.Neuron protection as a therapeutic target in acute ischemic stroke. Current Topics in Medicinal Chemistry 2009;9:1317-34.
40. Vaishnav A, Lutsep HL. GABA agonist: clomethiazole. Current Medical Research and Opinion 2002;18:S5-8.
41. Visser SA, Pozarek S, Martinsson S, Forsberg T, Ross SB, Gabrielsson J. Rapid and long-lasting tolerance to clomethiazole-induced hypothermia in the rat. European Journal of Pharmacology 2005;512:139-51.
42. Warlow CP, Dennis MS, van Gijn J, Hankey GJ, Sandercock PAG, Bamford JM, et al.What caused this transient or persistent ischemic event?. Stroke: A Practical Guide to Management. 2nd Edition. Oxford: Wiley-Blackwell, 2001.
43. World Health Organization. The atlas of heart disease and stroke. http://www.who.int/cardiovascular_diseases/resources/atlas/en (accessed 9 June 2011).
44. Wilby MJ, Hutchinson PJ. The pharmacology of chlormethiazole: a potential neuroprotective agent?. CNS Drug Reviews 2004;10:281-94.
45. Zingmark PH, Ekblom M, Odergren T, Ashwood T, Lyden P, Karlsson MO, et al.Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients. British Journal of Clinical Pharmacology 2003;56:173-83.
46. Zubcevic J, Potts JT. Role of GABAergic neurons in the nucleus tractus solitarii in modulation of cardiovascular activity. Experimental Physiology 2010;95:909-18.
47. Liu J, Wang L. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD009622]